Dossier
BeOne Medicine
Coverage of BeOne Medicine in the Nexus archive.
- Hang Seng Index review to boost market capitalisation by 4.5%: Goldman Sachs
Goldman Sachs predicts the latest Hang Seng Index review will increase its market capitalization by 4.5%, raising it to $2.15 trillion, with additions including BeOne Medicine, Chalco, and J&T Global Express. The review is expected to attract buying interest in stocks like Tencent Holdings and biotech firm BeOne Medicine.